Diabetes

Top Story

Strategies needed to engage younger women with National Diabetes Prevention Program

Strategies needed to engage younger women with National Diabetes Prevention Program
September 22, 2017

Women aged 39 years or younger with prediabetes or past gestational diabetes are half as likely to enroll in a National Diabetes Prevention Program and less likely to attend at least one session vs. women aged at least 40 years, according to findings published in the American Journal of Preventive Medicine.

“Efforts to reduce material obesity and diabetes risk during pregnancy have been largely ineffective, and there is a growing consensus that delivering lifestyle interventions during pregnancy may be ‘too little, too late,’” Natalie D. Ritchie, PhD, of the department of psychiatry at the University of Colorado School of Medicine in Aurora, and colleagues wrote. “Effective prevention efforts are needed prior to conception and subsequent pregnancies to halt the transgenerational cycle of obesity and diabetes.”

In the Journals PlusPerspective

Carbohydrate consumption timing affects glucose, insulin excursions

September 22, 2017
Adults with type 2 diabetes who consumed carbohydrates last during their meals had lower glucose peaks and insulin excursions and higher GLP-1 excursions compared with…
In the Journals Plus

Kidney disease ‘virtually universal’ at long durations of type 1 diabetes

September 22, 2017
Patients with type 1 diabetes duration of 50 years are more likely than not to experience some form of kidney disease, and although incidence of end-stage renal disease…
In the Journals Plus

Abdominal obesity with diabetes doubles risk for cognitive impairment

September 21, 2017
Among older Chinese adults with abdominal obesity, having type 2 diabetes more than doubled the risk for developing cognitive impairment, although neither condition was…
More Headlines »
CME

Rapid Response from Austin: Expanding Options in Type 2 Diabetes Management

This activity is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Approximately 150 million people worldwide have diabetes mellitus and this number is expected to double by 2025…
More »
GI Bookshelf

Chapter 5: Dysplasia And Colorectal Cancer

From Clinical Challenges and Complications of IBD
More »
Resource Centers
American Association of Nurse Practitioners National Conference

American Association of Nurse Practitioners National Conference

Video
Meeting News Coverage

VIDEO: Empagliflozin significantly reduces microvascular outcomes

September 16, 2016
More »
Advertisement
Advertisement